Cervical cancer screening in developing countries

Primary Care Update for Ob/Gyns

Volumn 7, Issue 3, 2000, Pages 118-123

  Soler, Maria Elena ^a   Gaffikin, Lynne ^b   Blumenthal, Paul D ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b Eval and Res Technol for Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; CRYOTHERAPY; CYTOLOGY; DEVELOPING COUNTRY; FEMALE; HUMAN; MASS SCREENING; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 0034611972     PISSN: 1068607X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1068-607X(00)00032-9     Document Type: Article

References (22)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers. Int J Cancer. 54:1993;594-606.
2. Murphy W.M., Coleman S.A. The long-term course of carcinoma in situ of the uterine cervix. Cancer. 38:1976;957-963.
3. DiSaia PJ, Creasman WT. Clinical gynecologic oncology. St. Louis, MO: Mosby, 1997.
4. Bishop A, Sherris J, Tsu V. Cervical dysplasia treatment in developing countries: A situation analysis. Seattle, WA: PATH, 1995.
5. Center for Disease Control. http: //www.cdc.gov/nchswww/data/ hus_95pdf.
6. Kessler I.I. Cervical cancer epidemiology in historical perspective. J Reprod Med. 12:1974;173-185.
7. IARC. Monographs on the evaluation of carcinogenic risks to humans. Number 64 - human papillomaviruses. Lyon, France: IARC, 1995.
8. Holowaty P., Miller A.B., Rohan T., et al. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 91:1999;252-258.
9. Peterson O. Spontaneous course of cervical precancerous conditions. Am J Obstet Gynecol. 72:1956;1063-1068.
10. Reeves W.C., Brinton L.A., Garcia M., et al. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med. 320:1989;1437-1441.
11. Maiman M. Cervical neoplasia in women with HIV infection. Oncology. 8:1994;83-89.
12. Gaarenstoom K.N., Melkert P., et al. Human papilloma virus DNA and genotypes Prognostic factors for progression of CIN . Int J Gynecol Cancer. 4:1994;73-78.
13. Coker A.L., Rosenberg A.J., et al. Active and passive cigarette smoke exposure and cervical neoplasia. Ca Epid Biomark Prev. 1:1992;349-356.
14. Abwao S, Greene P, Sanghvi H, Tsu V, Winkler J, eds. Prevention and control of cervical cancer in the East and Southern Africa region. Summary of proceedings of regional meeting held in Nairobi, Kenya, 29 March to 1 April, 1998. Seattle, WA: PATH, 1998.
15. Gaffikin L, Blumenthal, eds. Workshop proceedings: Alternatives for cervical cancer screening and treatment in low-resource settings. Baltimore, MD: JHPIEGO Corporation, 1997.
16. Visual inspection with acetic acid for cervical cancer screening Test qualities in a primary care setting . Lancet. 353:1999;869-873.
17. Sankaranarayanan R., Shyamalakumary B., Wesley R., et al. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Int J Cancer. 33:1999;817-825.
18. Monsonego J. Spontaneous screening: Benefits and limitations. In: Franco E, Monsonego J, eds. New developments in cervical cancer screening and prevention. Victoria, Australia: Blackwell Science Ltd., 1996:220-40.
19. Parkin D.M., Sankaranarayanan R. Prevention of cervical cancer in developing countries. Tha Obstet Gynecol. 11:(suppl 1):1999;3-20.
20. Mitchell M.F., Tortolero-Luna G, Cook E., et al. A randomized clinical trial of cryotherapy, laser vaporization and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol. 92:1998;737-744.
21. Montz F.J. Impact of therapy for cervical intraepithelial neoplasia fertility. Am J Obstet Gynecol. 175:1996;1129-1136.
22. Kitchener H.C., Symonds P. Detection of cervical intraepithelial neoplasia in developing countries. Lancet. 353:1999;856-857.